has role has attribute value has attribute antimetabolite antiviral drug didanosine 2',3'-dideoxyinosine 2,3-dideoxyinosine 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one A purine 2',3'-dideoxyribonucleoside that is inosine in which the hydroxy groups at both the 2' and the 3' positions on the sugar moiety have been replaced by hydrogen. An antiviral drug, it is used as a medication to treat HIV/AIDS. Beilstein:3619529 C10H12N4O3 CAS:69655-05-6 CHEBI:490877 DDI Didanosine DrugBank:DB00900 Drug_Central:869 LINCS:LSM-6017 OC[C@@H]1CC[C@@H](O1)n1cnc2c1nc[nH]c2=O PMID:10386939 PMID:1619614 PMID:17046264 PMID:18549801 PMID:29438107 Reaxys:3619529 Wikipedia:Didanosine ddI ddI ddIno didanosina didanosine didanosinum dideoxyinosine organic molecular entity HIV-1 reverse transcriptase inhibitor EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor drug liver toxicity Most-DILI-Concern